Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zheng Xu, Dalong Hu, Laurence Don Wai Luu, Sophie Octavia, Anthony D. Keil, Vitali Sintchenko, Mark M. Tanaka, Frits R. Mooi, Jenny Robson & Ruiting Lan. (2022) Genomic dissection of the microevolution of Australian epidemic Bordetella pertussis. Emerging Microbes & Infections 11:1, pages 1460-1473.
Read now
Read now
Timo Vesikari, Jin Xu, David R. Johnson, Jessie Hall, Tomáš Marček, Michelle G. Goveia, Camilo J. Acosta & Andrew Wen-Tseng Lee. (2020) Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines. Human Vaccines & Immunotherapeutics 16:4, pages 867-874.
Read now
Read now
Pablo Obando-Pacheco, Irene Rivero-Calle, Peter Francis Raguindin & Federico Martinón-Torres. (2019) DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age. Expert Review of Vaccines 18:11, pages 1115-1126.
Read now
Read now
Chukiat Sirivichayakul, Pornthep Chanthavanich, Kriengsak Limkittikul, Claire-Anne Siegrist, Wassana Wijagkanalan, Pailinrut Chinwangso, Jean Petre, Pham Hong Thai, Mukesh Chauhan & Simonetta Viviani. (2017) Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults. Human Vaccines & Immunotherapeutics 13:1, pages 136-143.
Read now
Read now
Jan T Poolman. (2014) Pertussis vaccines. Expert Review of Vaccines 13:9, pages 1067-1069.
Read now
Read now
Articles from other publishers (20)
Soraya Matczak, Valérie Bouchez, Pauline Leroux, Thibaut Douché, Nils Collinet, Annie Landier, Quentin Giai Gianetto, Sophie Guillot, Julia Chamot-Rooke, Milena Hasan, Mariette Matondo, Sylvain Brisse & Julie Toubiana. (2023) Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype. Microbes and Infection 25:7, pages 105152.
Crossref
Crossref
Beatriz Miguelena Chamorro, Karelle De Luca, Gokul Swaminathan, Stéphanie Longet, Egbert Mundt & Stéphane Paul. (2023) Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations. Clinical Microbiology Reviews.
Crossref
Crossref
Nao Otsuka, Kentaro Koide, Masataka Goto, Kazunari Kamachi & Tsuyoshi Kenri. (2023) Fim3-dependent autoagglutination of Bordetella pertussis. Scientific Reports 13:1.
Crossref
Crossref
Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan & Xiaoming Yang. (2023) Coping Strategies for Pertussis Resurgence. Vaccines 11:5, pages 889.
Crossref
Crossref
Alba Mir-Cros, Albert Moreno-Mingorance, M. Teresa Martín-Gómez, Raquel Abad, Iván Bloise, Magda Campins, Alejandro González-Praetorius, M. Nieves Gutiérrez, Héctor Martín-González, Carmen Muñoz-Almagro, M. Ángeles Orellana, Manuela de Pablos, Josep Roca-Grande, Carlos Rodrigo, M. Elena Rodríguez, Sonia Uriona, M. José Vidal, Tomàs Pumarola, M. Nieves Larrosa & Juan José González-López. (2022)
Pertactin-Deficient
Bordetella pertussis
with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018
. Emerging Infectious Diseases 28:5, pages 967-976.
Crossref
Crossref
Noémie Lefrancq, Valérie Bouchez, Nadia Fernandes, Alex-Mikael BarkoffThijs BoschTine Dalby, Thomas Åkerlund, Jessica Darenberg, Katerina Fabianova, Didrik F. VestrheimNorman K. Fry, Juan José González-López, Karolina Gullsby, Adele Habington, Qiushui HeDavid Litt, Helena Martini, Denis Piérard, Paola Stefanelli, Marc Stegger, Jana ZavadilovaNathalie Armatys, Annie Landier, Sophie GuillotSamuel L. Hong, Philippe Lemey, Julian Parkhill, Julie ToubianaSimon Cauchemez, Henrik Salje & Sylvain Brisse. (2022)
Global spatial dynamics and vaccine-induced fitness changes of
Bordetella pertussis
. Science Translational Medicine 14:642.
Crossref
Crossref
Marta Prygiel, Ewa Mosiej, Karol Wdowiak, Paulina Górska, Maciej Polak, Klaudia Lis, Katarzyna Krysztopa-Grzybowska & Aleksandra Anna Zasada. (2021) Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model. Medical Microbiology and Immunology 210:5-6, pages 251-262.
Crossref
Crossref
Valérie Bouchez, Sophie Guillot, Annie Landier, Nathalie Armatys, Soraya Matczak, Julie Toubiana & Sylvain Brisse. (2021) Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018. Eurosurveillance 26:37.
Crossref
Crossref
Atefeh Ghasemnejad, Samira Bazmara, Mahsa Shadmani & Kamran Pooshang Bagheri. (2021) Designing a New Multi-Epitope Pertussis Vaccine with Highly Population Coverage Based on a Novel Sequence and Structural Filtration Algorithm. IEEE/ACM Transactions on Computational Biology and Bioinformatics 18:5, pages 1885-1892.
Crossref
Crossref
Jakub Drzmisek, Daniel Stipl, Denisa Petrackova, Branislav Vecerek & Ana Dienstbier. (2021) Omics Analysis of Blood-Responsive Regulon in Bordetella pertussis Identifies a Novel Essential T3SS Substrate. International Journal of Molecular Sciences 22:2, pages 736.
Crossref
Crossref
Caitlín Ní Chasaide & Kingston H.G. Mills. (2020) Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract. Vaccines 8:4, pages 621.
Crossref
Crossref
Kalyan K. Dewan, Bodo Linz, Susan E. DeRocco & Eric T. Harvill. (2020) Acellular Pertussis Vaccine Components: Today and Tomorrow. Vaccines 8:2, pages 217.
Crossref
Crossref
I. G. Bazhanova, M. V. Britsina, N. U. Mertsalova & M. N. Ozeretskovskaya. (2019) Genetic variability of <i>Bordetella pertussis</i> and its role in vaccine prevention of pertussis. Journal of microbiology, epidemiology and immunobiology 96:4, pages 98-105.
Crossref
Crossref
Tetsuo Nakayama, Eitaro Suzuki & Atsuya Noda. (2019) Vaccine acquired pertussis immunity was weakened at 4 years of age and asymptomatic pertussis infection was suspected based on serological surveillance. Journal of Infection and Chemotherapy 25:8, pages 643-645.
Crossref
Crossref
Funbi Akinola, Rudzani Muloiwa, Gregory, D Hussey, Violette Dirix, Benjamin Kagina & Edina Amponsah-Dacosta. (2019) Assessment of humoral and cell-mediated immune responses to pertussis vaccination: a systematic review protocol. BMJ Open 9:6, pages e028109.
Crossref
Crossref
Anne Marie Queenan, David J. Dowling, Wing Ki Cheng, Kellen Faé, Jeffrey Fernandez, Peter J. Flynn, Sweta Joshi, Spencer E. Brightman, Juan Ramirez, Jan Serroyen, Selma Wiertsema, Alexandre Fortanier, Germie van den Dobbelsteen, Ofer Levy & Jan Poolman. (2019) Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine 37:1, pages 80-89.
Crossref
Crossref
Alex-Mikael Barkoff & Qiushui He. 2019. Pertussis Infection and Vaccines. Pertussis Infection and Vaccines
19
33
.
Christiane S. Eberhardt & Claire-Anne Siegrist. (2017) What Is Wrong with Pertussis Vaccine Immunity?. Cold Spring Harbor Perspectives in Biology 9:12, pages a029629.
Crossref
Crossref
Nao Otsuka, Nicole Guiso & Valérie Bouchez. (2017) The length of poly(C) stretch in the Bordetella pertussis Pfim3 promoter determines the vag or vrg function of the fim3 gene. Microbiology 163:9, pages 1364-1368.
Crossref
Crossref
Inonge van Twillert, Axel A. Bonačić Marinović, Betsy Kuipers, Jacqueline A. M. van Gaans-van den Brink, Elisabeth A. M. Sanders & Cécile A. C. M. van Els. (2017) Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis. Scientific Reports 7:1.
Crossref
Crossref